Corticosterone-attenuating and anxiolytic properties of mecamylamine in the rat

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 25, Issue 3, 2001, Pages 609-620

  Newman, Mary B ^a   Nazian, Stanley J ^a   Sanberg, Paul R ^a   Diamond, David M ^a   Shytle, R Douglas ^a  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

Anxiety; Corticosterone; Elevated plus maze; Mecamylamine; Stress

Indexed keywords

ACETYLCHOLINE; CHOLINERGIC RECEPTOR; CORTICOSTERONE; MECAMYLAMINE; NICOTINE; NICOTINIC RECEPTOR BLOCKING AGENT;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANXIETY NEUROSIS; ARTICLE; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; DOSE RESPONSE; GILLES DE LA TOURETTE SYNDROME; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MALE; MAZE TEST; NONHUMAN; RAT; STRESS; TRANQUILIZING ACTIVITY;

ANIMALS; ANTI-ANXIETY AGENTS; ANXIETY; CATS; CORTICOSTERONE; DOSE-RESPONSE RELATIONSHIP, DRUG; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; MALE; MECAMYLAMINE; NICOTINIC ANTAGONISTS; PITUITARY-ADRENAL SYSTEM; RATS; RATS, SPRAGUE-DAWLEY; STRESS, PSYCHOLOGICAL;

EID: 0035037920     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0278-5846(00)00178-0     Document Type: Article

References (36)

1. Nicotinic receptor agonists exhibit anxiolytic-like effects on the elevated plus-maze test
2. Differential improvement in memory-related task performance with nicotine by aged male and female rhesus monkeys
3. Regulation of rat hypothalamic corticotropin-releasing hormone secretion in vitro: Potential clinical implications
4. Recovery of the rat hypothalamic-pituitary-adrenal axis after discontinuation of prolonged treatment with the synthetic glucocorticoid agonist dexamethasone
5. Enhanced stress responsivity of Tourette syndrome patients undergoing lumber puncture
6. Elevated cerebrospinal fluid corticotropin-releasing factor in Tourette's syndrome: Comparison to obsessive compulsive disorser and normal contols
7. Pharmacological characterization of recombinant human neuronal nicotinic acetylcholine receptors h alpha 2 beta 2, h alpha 2 beta 4, h alpha 3 beta 2, h alpha 3 beta 4, h alpha 4 beta 2, h alpha 4 beta 4 and h alpha 7 expressed in Xenopus oocytes
8. Exposing rats to a predator impairs spatial working memory in the radial arm water maze
9. Nicotine-like behavioral effect after small dose of mecamylamine in roman high-avoidance rats
10. Cigarette smoke and behavior: Some recent developments
11. The effect of small doses of mecamylamine on shuttlebox behavior in the guinea-pig
12. New strategies in the search for anxiolytics
13. Endogenous acetylcholine in the dorsal hippocampus reduces anxiety through actions on nicotinic and muscarinic 1 receptors
14. Chronic fluoxetine in tests of anxiety in rat lines selectively bred for differential 5-HT1a receptor function
15. A five minute experience in the elevated plus-maze alters the state of the benzodiazepine receptor in the dorsal raphe nucleus
16. Stimulation of benzodiazepine receptors in the dorsal hippocampus and median raphe reveals differential GABAergic control in two animal tests of anxiety
17. Acetylcholine and depression
18. Cholinomimetric and anticholinergic drugs used to investigate and acetylcholine hypothesis of affective disorders and stress
19. Bidirectional effects of nicotine on anxiety and the role of the dorsal hippocampus
20. Serotonergic and cholinergic interaction in the regulation of pituitary-adrenal function in rats
21. Corticotropin-releasing factor, norepinephrine, and stress
22. Response of the hypothalamo-pituitary-adrenal axis to nicotine
23. Catecholamines mediate nicotine-induced adrenocorticotropin secretion via alpha-adrenergic receptors
24. Exposing rats to a predator blocks primed burst potentiation in the hippocampus in vitro
25. Locomotor behavioral effects of prenatal and postnatal nicotine exposure in rat offspring
26. The presence of corticotropin-releasing factor-like immunoreactive synaptic vesicles in axon terminals with nicotinic acetylcholine receptor-like immunoreactivity in the median eminence of the rat
27. Modulation of behaviour on trials 1 and 2 in the elevated plus-maze test of anxiety after systemic and hippocampal administration of nicotine
28. Stimulation of nicotinic receptors in the lateral septal nucleus increases anxiety
29. Interleukin-2 (IL-2) induces corticotropin-releasing factor (CRF) release from the amygdala and involves a nitric oxide-mediated signaling; comparison with the hypothalamic response
30. The topography of amphetamine and scopolamine-induced hyperactivity: Toward an activity print
31. Treatment of Tourette's syndrome with mecamylamine
32. Digiscan activity: Automated measurement of thigmotactic and stereotypic behavior in rats
33. Cholinergic influences on hypothalamic-pituitary-adrenocortical activity of stressed rats: An approach utilizing agonists and antagonists
34. Effects of nicotinic agonists and antagonists on N-methyl-D-aspartate-induced 3H-norepinephrine release and 3H-(1-[1-(2-thienyl)cyclohexyl]-piperidine) binding in rat hippocampus